光明生物产业集群很亮眼 国家生物制造产业创新中心与建发·新美合成生物产业园达成战略合作

Core Insights - The National Bio-Manufacturing Industry Innovation Center and Jianfa New Mei Synthetic Biology Industrial Park have established a strategic partnership to create an innovation hub and industrial transformation base in China's synthetic biology sector [1][2]. Group 1: Strategic Collaboration - The National Bio-Manufacturing Industry Innovation Center is the first national-level innovation platform in the bio-manufacturing field in China, aimed at enhancing key common technology collaboration and building an innovative ecosystem [1]. - Jianfa New Mei Synthetic Biology Industrial Park is positioned as a high-end life sciences industrial park focusing on bio-materials and bio-foods, with significant support policies and a complete hardware setup [1][2]. Group 2: Industry Development - The Guangming District has attracted 123 synthetic biology companies with a total valuation of nearly 40 billion yuan, generating an annual output value of over 4 billion yuan in the synthetic biology industry cluster [2]. - A planned investment of 500 million yuan will support industry innovation, alongside the establishment of a 1.5 billion yuan Shenzhen Synthetic Biology Industry Fund to enhance the local synthetic biology ecosystem [2]. Group 3: Future Prospects - The strategic collaboration aims to link technology, capital, and market resources, facilitating the transition of the synthetic biology industry from technological breakthroughs to commercialization [2]. - The partnership is expected to help companies gain a competitive edge in strategic fields such as healthcare and green energy, contributing to the global bio-economy [2].